Processing

Please wait...

Settings

Settings

Goto Application

1. WO2002004412 - TYROSINE DERIVATIVES AS PHOSPHATASE INHIBITORS

Publication Number WO/2002/004412
Publication Date 17.01.2002
International Application No. PCT/US2001/041271
International Filing Date 05.07.2001
Chapter 2 Demand Filed 28.01.2002
IPC
C07C 237/22 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
237Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
02having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
22having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
C07C 311/13 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
311Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
12of an unsaturated carbon skeleton containing rings
13the carbon skeleton containing six-membered aromatic rings
C07C 311/19 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
311Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
16having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
19to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
C07C 311/29 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
311Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
29having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
C07D 209/14 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
209Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
02condensed with one carbocyclic ring
04Indoles; Hydrogenated indoles
10with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
C07D 209/16 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
209Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
02condensed with one carbocyclic ring
04Indoles; Hydrogenated indoles
10with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
16Tryptamines
CPC
A61P 3/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
A61P 43/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
A61P 7/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
7Drugs for disorders of the blood or the extracellular fluid
12Antidiuretics, e.g. drugs for diabetes insipidus
C07C 237/22
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
237Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
02having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
22having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
C07C 311/13
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
311Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
12of an unsaturated carbon skeleton containing rings
13the carbon skeleton containing six-membered aromatic rings
Applicants
  • ARRAY BIOPHARMA INC. [US]/[US] (AllExceptUS)
  • AMGEN INC. [US]/[US] (AllExceptUS)
  • BURGESS, Laurence, E. [US]/[US] (UsOnly)
  • GAUDINO, John [US]/[US] (UsOnly)
  • GRONEBERG, Robert, D. [US]/[US] (UsOnly)
  • NORMAN, Mark, H. [US]/[US] (UsOnly)
  • RODRIGUEZ, Martha, E. [US]/[US] (UsOnly)
  • SUN, Xicheng [US]/[US] (UsOnly)
  • WALLACE, Eli, M. [US]/[US] (UsOnly)
Inventors
  • BURGESS, Laurence, E.
  • GAUDINO, John
  • GRONEBERG, Robert, D.
  • NORMAN, Mark, H.
  • RODRIGUEZ, Martha, E.
  • SUN, Xicheng
  • WALLACE, Eli, M.
Agents
  • DOCTER, Stephen
Priority Data
60/216,20106.07.2000US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) TYROSINE DERIVATIVES AS PHOSPHATASE INHIBITORS
(FR) PREPARATION D'INHIBITEURS DE PHOSPHATASE
Abstract
(EN) Disclosed are compounds of the Formula (I), and pharmaceutically acceptable salts and prodrugs thereof, wherein A, B, R1, R2, R3, R4 and R5 are as defined in the specification. Such compounds are tyrosine phosphatase inhibitors and useful in the treatment or prevention of Type II Diabetes Mellitus. Also encompassed by the invention are formulations comprising the noted compounds, processes for preparing such compounds, a method for treating or preventing Type II Diabetes Mellitus.
(FR) L'invention concerne des composés représentés par la formule (I), des sels et des promédicaments de ceux-ci acceptables du point de vue pharmaceutique. Dans cette formule (I), A, B, R1, R2, R3, R4 et R5 sont tels que définis dans la description. De tels composés sont des inhibiteurs de la tyrosine phosphatase et sont utiles dans le traitement ou la prévention du diabète sucré de type II. L'invention concerne également des préparations contenant lesdits composés, des procédés de préparation de tels composés, ainsi qu'un procédé de traitement ou de prévention du diabète sucré de type II.
Related patent documents
ZA200300118This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
IN60/KOLNP/2003This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
NO20030061This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
CN01815254.6This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
Latest bibliographic data on file with the International Bureau